What does the evidence say about Magnesium Migraine Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Magnesium Migraine Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Sex-specific management of migraine a systematic review and consensus statement from the European Headache Federation (EHF). [Braca S (2026); evidence level 1] - Associated symptoms may include nausea, vomiting, photophobia, and phonophobia []. [Rodriguez Juan Pablo (2025); evidence level 3] - Hormonal shifts during breastfeeding might also affect migraine occurrence, although the evidence is not definitive []. [Rodriguez Juan Pablo (2025); evidence level 3] - Similarly, another systematic review found a 7.7% migraine prevalence in this age group, with girls experiencing migraine more often than boys []. [Rodriguez Juan Pablo (2025); evidence level 3] - Secondary headaches are triggered by an existing medical problem, such as issues with blood vessels, tumors, infections, or changes in pressure or volume within the skull. [Rodriguez Juan Pablo (2025); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.